Live feed
Filing
SC 13D/A
SC 13D/A0001104659-15-050880·EPIRUS Biopharmaceuticals, Inc.
Schedule 13D ownership disclosure
EPIRUS BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 29428P107
Event date: 2015-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 346,641
- Percent of class
- 1.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-050880
- Form type
- SC 13D/A
- Filer
- EPIRUS Biopharmaceuticals, Inc.
- CIK
- CIK 1135906
- Filed
- Jul 13, 2015
- Reporting period
- Jun 15, 2015
- Description
- Schedule 13D beneficial ownership